Imagenebio, Inc.
Records under this name other than the patents Imagenebio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 9 of 9 · Back to Imagenebio, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,274,082 | Tead Inhibitors and Uses Thereof now held by The Ehe Foundation In force · High confidence | In force | High confidence | |
| US 11,458,149 | Tead Inhibitors and Uses Thereof now held by The Ehe Foundation In force · High confidence | In force | High confidence | |
| US 11,760,728 | Tead Inhibitors and Uses Thereof now held by The Ehe Foundation In force · High confidence | In force | High confidence | |
| US 11,925,651 | Tead Inhibitors and Uses Thereof now held by The Ehe Foundation In force · Medium confidence | In force | Medium confidence | |
| US 12,577,208 | Tead Inhibitors and Uses Thereof now held by The Ehe Foundation In force · High confidence | In force | High confidence | |
| 18/039,781 | Tead Inhibitors and Uses Thereof now held by The Ehe Foundation Abandoned Abandoned May 25, 2024 | Abandoned | Abandoned May 25, 2024 | |
| 18/273,411 | Combination of a 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE Tead Inhibitor with an Egfr Inhibitor And/Or Mek Inhibitor for Use in the Treatment of Lung Cancer now held by The Ehe Foundation Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/554,057 | Mek Inhibitors and Uses Thereof Abandoned Abandoned Oct 6, 2024 | Abandoned | Abandoned Oct 6, 2024 | |
| 19/355,035 | Mek Inhibitors and Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |